Perspective Therapeutics
Develops targeted alpha-particle radiotherapies for cancer treatment.
Company facts
- Founded
- 1983
- Employees
- 140
- Headquarters
- United States
- Type
- Public
- Listed
- NYSE American: CATX
- Subsidiaries
- Isoray Medical, Viewpoint Molecular Targeting